Cracker Barrel stock surges after President Trump's rebranding advice — Neutral
CBRL Finbold — August 26, 2025Cracker Barrel's (NASDAQ: CBRL) share price rose on Tuesday as investors reacted to a rebranding intervention by President Donald Trump. The move follows backlash against the company's recent rebranding effort.
Thoma Bravo to Expand AI-Powered Customer Experience Offering by Acquiring Verint — Positive
VRNT PYMNTS — August 26, 2025Software investment firm Thoma Bravo plans to expand its artificial intelligence-powered customer experience (CX) offering by acquiring CX automation firm Verint Systems. The company agreed to buy Verint in an all-cash transaction reflecting an enterprise value of $2 billion, according to a Monday (Aug. 25) press release.
Gold gains on uncertainty surrounding Trump firing Fed official — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — August 26, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
Is the Options Market Predicting a Spike in Corning Stock? — Neutral
GLW Zacks Investment Research — August 26, 2025Investors need to pay close attention to Corning stock based on the movements in the options market lately.
Acadia & ECU Health Expand Behavioral Care Access in North Carolina — Positive
ACHC Zacks Investment Research — August 26, 2025ACHC opens a 144-bed hospital with ECU Health in Greenville, NC, boosting care access and expanding its behavioral health reach.
JBL Is Betting Big on AI Data Center Market: Will This Drive Growth? — Positive
JBL Zacks Investment Research — August 26, 2025Jabil rides on AI data center demand with portfolio expansions, focus on innovation and collaboration with other industry leaders.
KE Holdings Inc. (BEKE) Q2 2025 Earnings Call Transcript — Neutral
BEKE Seeking Alpha — August 26, 2025KE Holdings Inc. (NYSE:BEKE ) Q2 2025 Earnings Conference Call August 26, 2025 8:00 AM ET Company Participants Siting Li - Investor Relations Director & Joint Company Secretary Tao Xu - CFO & Executive Director Yongdong Peng - Co-Founder, Chairman & CEO Conference Call Participants Griffin Chan - Citigroup Inc. Exchange Research John Lam - UBS Investment Bank, Research Division Qi Chen - JPMorgan Chase & Co, Research Division Timothy Zhao - Goldman Sachs Group, Inc., Research Division Xiaodan Zhang - China International Capital Corporation Limited, Research Division Operator Hello, ladies and gentlemen. Thank you for standing by for KE …
Subscribers to Chart of the Week received this commentary on Sunday, August 24.
Gaotu Techedu Inc. (GOTU) Q2 2025 Earnings Call Transcript — Neutral
GOTU Seeking Alpha — August 26, 2025Gaotu Techedu Inc. (NYSE:GOTU ) Q2 2025 Earnings Conference Call August 26, 2025 8:00 AM ET Company Participants Catherine Chen - Corporate Participant Nan Shen - CFO & Senior VP Xiangdong Chen - Founder, Chairman & CEO Conference Call Participants Yiran Sheng - CLSA Limited, Research Division Yishan Li - China Merchants Securities (HK) Co., Ltd, Research Division Operator Hello, ladies and gentlemen. Thank you for standing by, and welcome to the Gaotu Techedu Inc. Second Quarter 2025 Earnings Conference Call.
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin — Positive
CPRX Zacks Investment Research — August 26, 2025CPRX secures a key win as its Firdapse patent litigation settlement with Lupin shields U.S. sales from generic competition until 2035.
Durable Goods Orders Decreased Less Than Expected — Negative
BMO BNS LLY Zacks Investment Research — August 26, 2025Pre-market activity is somewhat better than earlier in the trading session this morning, following a less-bad Durable Goods report for July. We also appear to be bouncing around a bit more in recent trading days after a steadier level following August 2nd lows.
Immuneering Stock Rises 21.7% on Supply Agreement With LLY — Positive
IMRX Zacks Investment Research — August 26, 2025IMRX jumps 21.7% after striking a supply deal with Eli Lilly to test atebimetinib with the latter's olomorasib in non-small cell lung cancer.
Alphabet: Fear Pushes Price To Bargain Levels Investors Dream Of — Positive
GOOG GOOGL Seeking Alpha — August 26, 2025Google is trading at a steep discount versus peers, despite superior growth, profitability, and durable moats, due to overblown antitrust fears. Current antitrust actions are unlikely to fundamentally undermine Google's structural advantages or long-term profitability; even a breakup could unlock shareholder value. Ending default search payments could actually benefit shareholders by freeing up billions for higher-return growth initiatives like AI.
Is Progressive's Profitability Anchored by Combined Ratio? — Positive
PGR Zacks Investment Research — August 26, 2025PGR's profitability hinges on disciplined underwriting and a strong combined ratio, even as inflation and loss costs pressure margins.
Top Stock Movers Now: Eli Lilly, EchoStar, Constellation Brands, and More — Neutral
LLY Investopedia — August 26, 2025U.S. equities were little changed at midday on limited market-driving corporate earnings news and economic data. The Dow Jones Industrial Average, S&P 500, and Nasdaq all moved by small amounts.
Philip Morris Transformation Accelerates With IQOS and ZYN Growth — Negative
PM Zacks Investment Research — August 26, 2025PM's second-quarter results show smoke-free gains lifting revenues and profit, even as cigarette volumes continue to decline.
Unity vs. Roblox: Which 3D Content Stock Is the Better Buy Now? — Positive
RBLX U Zacks Investment Research — August 26, 2025U rebounds with ad-tech growth and enterprise expansion, while RBLX surges on engagement but faces losses and legal risks.
Bank of Nova Scotia: Still A Buy After Strong Q3 Earnings — Positive
BNS Seeking Alpha — August 26, 2025The Bank of Nova Scotia delivered a strong Q3, beating analyst expectations with 13.5% revenue growth and 15% higher adjusted earnings year-over-year. The bank's turnaround plan is progressing, focusing on shedding weaker international assets and emphasizing growth in Canada, the U.S., and Mexico. Canadian Banking results were mixed, with higher expenses and lower net interest margins, but return on equity rebounded to 18.4%.
Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins? — Neutral
NVO Zacks Investment Research — August 26, 2025NVO faces slowing GLP-1 momentum but leans on rare disease wins and new Wegovy approval to bolster growth.
Spotify is launching a messaging feature for its free and premium subscribers.